Lee's Pharmaceutical Holdings Limited (FRA:L1PA)

Market Cap	109.23M
Revenue (ttm)	155.81M
Net Income (ttm)	10.61M
Shares Out	n/a
EPS (ttm)	0.02
PE Ratio	10.30
Forward PE	n/a
Dividend	0.01 (2.97%)
Ex-Dividend Date	Sep 12, 2025

Volume	n/a
Average Volume	n/a
Open	0.1780
Previous Close	0.1780
Day's Range	0.1780 - 0.1780
52-Week Range	0.1310 - 0.2700
Beta	n/a
RSI	37.18
Earnings Date	Nov 17, 2025

About FRA:L1PA

Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman’s health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells Nadroparin Calcium injection and Livaracine to trea...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 1,022
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: L1PA

Financial Performance

In 2024, FRA:L1PA's revenue was 1.40 billion, an increase of 32.95% compared to the previous year's 1.05 billion. Earnings were 93.10 million, an increase of 457.55%.

Financial numbers in HKD